Mymd Pharmaceuticals (NASDAQ:QCLS – Get Free Report) and Boxlight (NASDAQ:BOXL – Get Free Report) are both small-cap technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, valuation, institutional ownership, analyst recommendations, earnings and risk.
Insider and Institutional Ownership
9.6% of Mymd Pharmaceuticals shares are held by institutional investors. Comparatively, 6.5% of Boxlight shares are held by institutional investors. 0.9% of Mymd Pharmaceuticals shares are held by insiders. Comparatively, 15.4% of Boxlight shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Risk & Volatility
Mymd Pharmaceuticals has a beta of 2.16, suggesting that its share price is 116% more volatile than the S&P 500. Comparatively, Boxlight has a beta of 0.81, suggesting that its share price is 19% less volatile than the S&P 500.
Analyst Ratings
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Mymd Pharmaceuticals | 1 | 0 | 0 | 0 | 1.00 |
| Boxlight | 1 | 0 | 0 | 0 | 1.00 |
Earnings & Valuation
This table compares Mymd Pharmaceuticals and Boxlight”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Mymd Pharmaceuticals | N/A | N/A | -$11.63 million | ($20.69) | -0.13 |
| Boxlight | $109.25 million | 0.04 | -$23.81 million | ($136.29) | -0.05 |
Mymd Pharmaceuticals has higher earnings, but lower revenue than Boxlight. Mymd Pharmaceuticals is trading at a lower price-to-earnings ratio than Boxlight, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Mymd Pharmaceuticals and Boxlight’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Mymd Pharmaceuticals | N/A | -91.64% | -47.48% |
| Boxlight | -20.96% | N/A | -22.79% |
About Mymd Pharmaceuticals
TNF Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on developing two novel therapeutic platforms that treat the causes of disease rather than addressing the symptoms. Its MYMD-1 is a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines. The MYMD-1 is being developed to treat diseases and disorders marked by acute or chronic inflammation. The company’s second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction, and epilepsy. The Supera-CBD is a novel synthetic derivative of cannabidiol (CBD) and is being developed to address and improve the growing CBD market, which includes FDA approved drugs and CBD products not regulated as drugs. TNF Pharmaceuticals, Inc. was formerly known as MyMD Pharmaceuticals, Inc. and changed its name to TNF Pharmaceuticals, Inc. in July 2024. The company was founded in 2014 and is headquartered in Baltimore, Maryland.
About Boxlight
Boxlight Corporation designs, produces, and distributes interactive technology solutions for the education, health, corporate, military, and government sectors in the Americas, Europe, the Middle East, Africa, and internationally. The company provides interactive and non-interactive flat panel displays and whiteboards, LED video walls, digital signages, classroom audio and campus communication, cameras and other peripherals, and media players; and accessory document cameras, teacher pads for remote control, assessment systems, and front-of-class display products under the Mimio and Clevertouch brands. It also offers MimioStudio Interactive Instructional software that enables the creation, editing, and presentation of interactive instructional lessons and activities; MimioMobile, a software accessory for MimioStudio; Oktopus Instructional and Whiteboarding software, which enables the creation, editing, and presentation of interactive instructional lessons and activities; Notes+, a software accessory; GameZones, a multi-student interactive gaming software; MimioConnect, an online student engagement platform; and LYNX, a lesson building app. In addition, the company provides Juno, a towering standard of sound quality that reinforces a teacher's voice; Mimio MyBot system for robotics learning; Robo3D printers; MyStemKits, which offers lesson plans for grades K-12 math and science teachers; MimioView document camera; EzRoom, an integrated AV solution; Lyrik, an amplification solution; and Conductor School Communication System, an IP-based campus-wide communication and control solution; and accessories, such as mobile carts, installation accessories, and wall-mount accessories for interactive LED flat-panels and audio solutions. Further, it offers classroom training, professional development, and educator certification services. The company was formerly known as Logical Choice Corporation. Boxlight Corporation was founded in 1985 and is headquartered in Duluth, Georgia.
Receive News & Ratings for Mymd Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mymd Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
